Physician

Kore K. Liow, MD

According to 2025 Medicare claims, Kore Liow, MD (NPI: 1366445306) practices neurology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is HAWAII PACIFIC NEUROSCIENCE LLC (NPI: 1043442908; TIN: 270622048) and primary practice location at 96817-1646.

Liow's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 391 traditional Medicare patients, billed 7,362 HCPCS/CPT codes, and received $399,081 in Medicare payments. The top billing code was 95819 (Measurement of brain wave activity (eeg), awake and asleep). Part D data shows 1,348 prescription claims across 332 beneficiaries totaling $592,672 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). DME data shows 336 claims. Open Payments data shows 165 records totaling $1,555,047. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $180,252 and ending at $399,081. Concurrently, Part D prescription costs have risen steadily, from $213,000 to $592,672. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,408 to $15,573.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	302	1,002	$180,252
2016	392	1,133	$296,647
2017	535	1,722	$334,983
2018	345	1,081	$249,199
2019	369	2,097	$269,426
2020	293	1,798	$97,260
2021	280	950	$187,028
2022	283	959	$216,273
2023	354	1,198	$255,768
2024	391	7,362	$399,081

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	161	1,063	$213,000
2016	177	1,286	$264,190
2017	292	1,405	$318,292
2018	197	1,083	$259,611
2019	200	1,177	$362,841
2020	213	1,113	$387,206
2021	236	942	$347,565
2022	212	1,137	$330,700
2023	303	1,402	$364,305
2024	332	1,348	$592,672

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	60	$1,320
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	107	336	$12,659

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95819	Measurement of brain wave activity (eeg), awake and asleep	154	190	$370
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	170	330	$143
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	179	348	$100
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	155	278	$25
93040	Electrocardiogram (ecg) 1 to 3 leads with review by physician	122	143	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	19	518	$275,291
Valtoco	Diazepam	30	777	$66,770
Botox	Onabotulinumtoxina	18	1,512	$22,890
Briviact	Brivaracetam	12	360	$18,264
Xcopri	Cenobamate	13	375	$18,083

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	13	79	$2,705
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	18	$1,763
A7030	Full face mask used with positive airway pressure device, each	N	N/R	17	$1,521
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	15	23	$1,269
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	17	27	$1,039

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	70	$1,784	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	95	$1,553,263	Biogen, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kore K. Liow, MD?

Tedicare shows public-source Medicare data for Kore K. Liow, MD (NPI 1366445306), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kore K. Liow, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kore K. Liow, MD?

Kore K. Liow, MD is linked to HAWAII PACIFIC NEUROSCIENCE LLC (billing NPI 1043442908) in the available physician profile data.

Does Kore K. Liow, MD have Open Payments data?

Kore K. Liow, MD has 165 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.